Interaction of bradykinin and prostaglandin E1 on cardiac pressor reflex and sympathetic afferents. Am. J. Physiol. 250 (Regulatory Integrative Comp. Physiol. 19): RIM-FU322,19&6.-Bradykinin applied to the epicardium stimulates cardiac sympathetic afferents and evokes a reflex increase in arterial blood pressure. In anesthetized cats we examined the potentiation of these effects by prostaglandin E1 ( PGEI) applied to the ventricular epicardium. We recorded cardiac afferent impulses from the second to the fifth left thoracic sympathetic rami. PGE, (0.1 pg/ml) alone had little effect on blood pressure, but it significantly increased the pressor response to bradykinin, and it reduced or abolished tachyphylaxis to repeated applications of bradykinin. Both mechanosensitive and chemosensitive sympathetic cardiac afferents were stimulated by bradykinin. Indomethacin (intravenous) caused a small reduction in the afferent response to bradykinin. Epicardial application of PGEl significantly increased the response (magnitude and duration) of chemosensitive endings to bradykinin but not that of mechanosensitive endings; however, PGE, abolished the tachyphylaxis of both chemosensitive and mechanosensitive endings to repeated applications of bradykinin. Because both bradykinin and prostaglandins are released in the ischemic myocardium, their interactive effect on cardiac sympathetic afferents could play a part in the sensory and reflex responses to myocardial ischemia. cardiac mechanosensitive afferents; cardiac chemosensitive afferents; cardiac pain; cardiac nociceptive reflex; tachyphylaxis to bradykinin; cardiac nociceptors BRADYKININ applied to the ventricular epicardium evokes a pressor reflex in dogs (22)(23)(24) and cats (21, 28). The reflex is initiated by cardiac afferents whose impulses travel to the spinal cord in sympathetic nerve branches (21, 22). Action potential studies have established that bradykinin stimulates cardiac sympathetic afferent fibers (1, 18, 26) and activates neurons in the spinothalamic tract and medullary reticular formation (4, 5, 28). Hence it seems likely that the peripheral pathways involved in the pressor reflex response are also concerned with the transmission of cardiac pain.
Physiol. 250 (Regulatory Integrative Comp. Physiol. 19): RIM-FU322,19&6.-Bradykinin applied to the epicardium stimulates cardiac sympathetic afferents and evokes a reflex increase in arterial blood pressure. In anesthetized cats we examined the potentiation of these effects by prostaglandin E1 ( PGEI) applied to the ventricular epicardium. We recorded cardiac afferent impulses from the second to the fifth left thoracic sympathetic rami. PGE, (0.1 pg/ml) alone had little effect on blood pressure, but it significantly increased the pressor response to bradykinin, and it reduced or abolished tachyphylaxis to repeated applications of bradykinin. Both mechanosensitive and chemosensitive sympathetic cardiac afferents were stimulated by bradykinin. Indomethacin (intravenous) caused a small reduction in the afferent response to bradykinin. Epicardial application of PGEl significantly increased the response (magnitude and duration) of chemosensitive endings to bradykinin but not that of mechanosensitive endings; however, PGE, abolished the tachyphylaxis of both chemosensitive and mechanosensitive endings to repeated applications of bradykinin. Because both bradykinin and prostaglandins are released in the ischemic myocardium, their interactive effect on cardiac sympathetic afferents could play a part in the sensory and reflex responses to myocardial ischemia. cardiac mechanosensitive afferents; cardiac chemosensitive afferents; cardiac pain; cardiac nociceptive reflex; tachyphylaxis to bradykinin; cardiac nociceptors BRADYKININ applied to the ventricular epicardium evokes a pressor reflex in dogs (22) (23) (24) and cats (21, 28) . The reflex is initiated by cardiac afferents whose impulses travel to the spinal cord in sympathetic nerve branches (21, 22) . Action potential studies have established that bradykinin stimulates cardiac sympathetic afferent fibers (1, 18, 26) and activates neurons in the spinothalamic tract and medullary reticular formation (4, 5, 28) . Hence it seems likely that the peripheral pathways involved in the pressor reflex response are also concerned with the transmission of cardiac pain.
The pressor response to epicardial bradykinin is potentiated by the local application of low concentrations of prostaglandin E1 (PGE1) (23, 24) , an effect comparable to the potentiation by PGE1 of bradykinin-evoked responses demonstrated in other physiological systems (11, 14, 15, 17, 25) . In addition, the tachyphylaxis that develops in dogs when bradykinin is applied to the epicardium for extended periods is reversed by application of prostaglandin (23) . The present experiments in cats were undertaken to examine these interactions of PGE1 and bradykinin on the pressor response and to elucidate the underlying changes in afferent nerve activity. We compared the interactive effects of PGEI and bradykinin on both chemosensitive and mechanosensitive cardiac sympathetic afferents (1).
METHODS

General
Cats (2.6-5.1 kg) were anesthetized with pentobarbital sodium (30-40 mg/kg iv) or with a mixture of urethan (200 mg/kg) and a-chloralose (40 mg/kg iv). During the recording of action potentials the cats were paralyzed with gallamine triethiodide (Flaxedil, Davis Geck; 2 mg/ kg iv). Periodically the effect of the gallamine triethiodide was allowed to wear off so that the depth of anesthesia could be adjusted; additional doses of anesthetic were given to maintain abolition of the cornea1 reflex.
The trachea was cannulated, and the lungs were ventilated with 50% 02 in air by a Harvard respirator. Tidal CO2 was monitored by a Beckman LB-l gas analyzer, and end-tidal PCO~ was maintained between 30 and 35 Torr. The chest was opened by removing the left second to seventh ribs. The pericardial sac was opened, and a pericardial cradle was fashioned to support the heart. Tracheal pressure was measured from a sidearm of the tracheal cannula. Blood pressure in the aortic arch and left ventricle was recorded through catheters inserted via a femoral artery and pulmonary vein, respectively. Pressures were recorded with Statham (P23Gb) strain gauges. Sympathetic afferent impulses were recorded (see below), and their frequency was counted by a ratemeter. All variables were recorded by an ultraviolet oscillograph, and all but the action potentials were recorded by a Grass polygraph*
In some experiments the left sympathetic chain and rami communicantes were intact, and we examined the reflex changes in mean aortic blood pressure produced by applying bradykinin or PGEl or both to the exposed epicardial surface. In other experiments we recorded afferent impulses from slips of the left sympathetic chain and rami and examined the changes in firing produced by applying bradykinin or PGEl or both to the epicardium. We exposed the left stellate ganglion and the second to the fifth left rami communicantes and associated sympathetic chain and recorded afferent impulses from fine filaments teased from the rami or chain. We routinely examined all filaments, whether active or silent, searching for afferent fibers arising from mechanosensitive and chemosensitive endings in the heart and adjacent great vessels inside the pericardium (1). Mechanosensitive endings were identified by their cardiac pattern of discharge and by their immediate and vigorous response when the receptor site was gently stroked with a fine probe or bristle; endings in the left heart were stimulated when the descending thoracic aorta was occluded briefly by a snare to increase blood pressure upstream (1). Chemosensitive endings had a sparse and irregular discharge without cardiac modulation, and their impulse activity changed little when vascular pressures were increased. Although they could be stimulated by probing or pinching the heart, the evoked discharge usually lagged behind the stimulus and had a pronounced afterdischarge (1). Many sympathetic afferent fibers have more than one ending apiece (2), but in the present study we confined our observations to one ending of each fiber whose impulses were recorded. We measured conduction velocities of some fibers (1).
Control firing frequency (impulses/s) was averaged over the 30 s before application of bradykinin or PGE1. Maximum frequency of the evoked discharge was the average firing counted over 3 s at the peak of the response. The latency of response was measured from the beginning of the application of bradykinin or PGE1. All values are expressed as means t SE. We used paired and unpaired t tests as appropriate to determine statistical significance. Differences were considered significant if P < 0.05.
RESULTS
Reflex Studies
Application of Bradykinin and PGEl Stock solutions of bradykinin triacetate (Sigma) (1 mg/ml in NaCl solution 0.9 g/100 ml) and PGEl (Upjohn) (1 mg in 0.1 ml ethyl alcohol + 0.9 ml 0.9% saline) were stored at .-20°C and were diluted as required with 0.9% saline. Bradykinin (0.01-10.0 pg/ml; usually 1 ml of a 1.0 pg/ml solution) was applied to the epicardium in 5-8 s. PGEl (0.1 pg/ml) was applied more slowly (0.3-0.5 ml/min for 15 min). The solutions were dripped over the epicardium from a syringe fitted with a long needle. Because endings may have been stimulated mechanically by the solution or chemically by the solvent, control applications of the appropriate solvent were made in all experiments. At the end of each experiment the test solution was aspirated and the pericardial sac washed out with warm saline. The various experimental protocols used in the reflex and afferent studies are described in RESULTS. In some experiments lidocaine (10 mg/ml) was applied to the epicardium. With one exception (see below), indomethacin was administered in all experiments to suppress endogenous prostaglandin synthesis. We were thus able to examine the effects of exogenous prostaglandin without the complication of possible changes in the level of endogenous prostaglandin synthesis. Indomethacin (Merck, Sharp and Dohme) was administered intravenously (5 mg/kg, dissolved in 10 ml 0.9% saline) at least 30 min before the first application of bradykinin or PGE1. Indomethacin was not administered in the control part of the experiments in which we specifically examined the possible effect of endogenous prostaglandin synthesis on the afferent response to bradykinin (see RESULTS).
The reflex effects of applying bradykinin to the epicardium were examined in cats treated with indomethatin to suppress endogenous prostaglandin synthesis. In preliminary experiments on six cats, dose-dependent pressor responses were obtained by applying 1 ml bradykinin solution (0.01-10 pg/ml) to the epicardium. The magnitude of the pressor responses varied from cat to cat but in a given cat was maximal or near maximal at a bradykinin concentration of 1 pg/ml. Therefore this concentration was used in subsequent experiments. Pressor responses could still be evoked after both cervical vagus nerves were cut but not after local anesthetic (lidocaine 10 mg/ml) was applied to the epicardium. Mean arterial blood pressure (124 t 6 mmHg) increased by 15 t 2 mmHg when bradykinin (1 pg/kg) was applied to the epicardial surface in 23 experiments on 15 cats. The pressor effect lasted -2 min ( ii;ii I-PGE( - pressor response were significantly greater than before application of PGE1, the magnitude increasing by an average of 54% (P < 0.005) and the duration by 50% (P < 0.002) (Fig. 1B) . Control applications of the appropriate solvents had no effect on blood pressure nor had they any effect on the pressor response to subsequent application of bradykinin. We next examined the effect of PGEl on the tachyphylaxis observed with repeated applications of bradykinin. When bradykinin was applied three times to the epicardium at intervals of 15 min, tachyphylaxis developed in six of seven cats, the magnitude and duration of the pressor response decreasing significantly (P < 0.05) between the first and third applications (Fig. 2 , applications 1-3). PGEr was then applied for 15 min. Bradykinin (Fig. 2, application 4) now evoked a pressor response that was greater, in both magnitude (P < 0.05) and duration (P < O.Ol), than the initial response. Moreover, in spite of an apparent downward trend, the responses to two subsequent applications of bradykinin (Fig. 2 , applications 5 and 6, each preceded by PGE1) were not significantly different from the first response after PGEr.
Action Potential Studies
Having shown that PGE, not only potentiated the magnitude and duration of the pressor response to bradykinin but also reduced the tachyphylaxis that usually developed with repeated applications of bradykinin, we next examined the afferent counterpart of these effects. We recorded impulses from 73 sympathetic afferent fibers with endings in the heart and intrapericardial parts of the great vessels. Fifty-six of the endings were mechanoreceptors (l), which discharged a single action potential in occasional cardiac cycles under control conditions. Occluding the descending aorta to increase arterial pressure and cardiac volume evoked pulsatile discharges of one to three action potentials with each cardiac cycle. The remaining 17 endings appeared to be primarily chemosensitive (1). They had a sparse and irregular discharge under control conditions, they never acquired a cardiac rhythm, and they were rarely stimulated by increases in cardiac volume. Although less responsive than mechanosensitive endings to mechanical stimulation, chemosensitive endings were more vigorously stimulated by bradykinin (see below). Satisfactory measurements of conduction velocities were obtained in 33 fibers: 26 fibers were A-fibers with velocities of 3.7-20.0 m/s (23 were mechanosensitive and 3 chemosensitive); 12 were C-fibers with velocities of 0.5-2.4 m/s (5 mechanosensitive, 7 chemosensitive). Thus 82% of mechanosensitive fibers whose conduction velocities were measured were myelinated, whereas 70% of chemosensitive fibers were nonmyelinated.
In the experiments described below we found no obvious differences between the responses of myelinated and nonmyelinated mechanosensitive fibers to bradykinin and PGEr nor between the responses of myelinated and nonmyelinated chemosensitive fibers.
Stimulation by bradykinin. When bradykinin was applied, mechanosensitive endings began to discharge one to three impulses with each cardiac cycle (Fig. 3, A and  B) . Chemosensitive fibers, on the other hand, discharged either continuously or in irregular bursts without cardiac modulation (Fig. 4) . The responses of the two types of ending had similar latencies (8-20 s) and durations (l-3 min), but the increase in frequency of discharge of chemosensitive endings was greater (Fig. 5, Table 1 ). The afferent responses were accompanied by a reflex increase in blood pressure in only about a third of experiments, probably because sympathetic afferent pathways had been interrupted for the recording of action potentials. When bradykinin was applied three times at intervals of 15 min, both mechanosensitive and chemosensitive responses decreased progressively, tachyphylaxis involving a reduction in both the peak frequency and the duration of discharge (Figs. 3, 6 , and 7; see below). As described previously (l), chemosensitive endings sometimes displayed a biphasic response to bradykinin, an early smaller increase in firing followed by a second more abrupt increase (Fig. 6, D and E) . We have no explanation for these biphasic responses: they did not occur consistently in repeated observations on a given fiber (Fig. 6, A and B) , and they were observed both before and after administration of PGE, or indomethacin. Effect of indomethacin on afferent response to bradykinin. To determine whether endogenous prostaglandins might be involved in the sympathetic afferent response to bradykinin, we compared the effects of bradykinin on two groups of mechanosensitive endings, each consisting of 20 endings; one group was in cats whose endogenous prostaglandin synthesis was unimpaired, the second was in cats that had received indomethacin. In similar fashion we compared the effects of bradykinin on two groups of chemosensitive endings, each group consisting of six endings. In cats treated with indomethacin the average control discharge of both mechanosensitive and chemosensitive endings was less, and the magnitude and duration of the response to bradykinin were less and the latency greater than in untreated cats (Table 1 ). These differences were small, and none were statistically significant, but their general direction suggested that endogenous prostaglandin release might be involved in the sympathetic afferent response to bradykinin and thus justified the use of indomethacin in the following action potential studies.
Effect of PGE, on afferent response to bradykinin. In indomethacin-treated cats we first examined the effect of PGE, alone, recording the activity of 21 mechanosensitive and 7 chemosensitive afferents over a period of 15 min while PGEl (0.1 pg/ml) was dripped slowly over the epicardial surface. PGEi itself caused a small but significant overall increase in the background activity (from 0.3 + 0.1 to 0.5 & 0.1 impulses/s, P < 0.05) of these 28 endings (Figs. 3 and 4) .
We next examined the effect of PGE, on the afferent response to bradykinin (Figs. 3, 4 , and 5). The response of 19 mechanosensitive endings to bradykinin was not significantly potentiated by PGEi (Fig. 5B) . However, the response of five chemosensitive fibers was markedly 120 150 potentiated (Fig. 4) , the magnitude of the response increasing on average by 67% and the duration by 59% (P < 0.05) (Fig. 5) . Effect of PGE, on tachyphylaxis to bradykinin. In observations on nine mechanosensitive and five chemosensitive afferents we examined the effect of PGE, on the tachyphylaxis that developed with repeated applications of bradykinin (Figs. 3 and 6 ). Tachyphylaxis was observed in 13 of the 14 fibers examined. We used a protocol (Fig. 7 ) similar to that employed in the corresponding reflex studies (Fig. 2) . After three control applications of bradykinin were made at intervals of 15 min, PGEi was dripped slowly onto the receptive field for 15 min; brady-PGE1, AND CARDIAC SYMPATHETIC AFFERENTS
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kinin was then applied at intervals of 15 min for as long as the fiber remained active (i.e., l-3 applications), PGEl being applied continuously in the intervals (Fig. 7) . The recording life of single sympathetic afferent fibers was often limited. Completion of the full experimental protocol depicted in Fig. 7 required 90 min or longer, and although we examined the response of all 14 fibers to the first post-PGE, application of bradykinin, we were able to complete the full protocol of three post-PGE, applications on only two mechanosensitive and two chemosensitive fibers. Nevertheless, a sufficient number of consecutive observations was completed to suggest that tachyphylaxis to bradykinin was reversed by PGEl (Fig.  7) . In the case of mechanosensitive endings, PGEl restored the excitatory effect of bradykinin to its initial level (Fig. 7A ). In the case of chemosensitive endings, PGEl not only reversed the tachyphylaxis to bradykinin but significantly potentiated the afferent response (P < 0.05); i.e., the responses after PGE1 application were greater than the initial response (Fig. 7B, application 1) .
DISCUSSION
The present experiments confirm that epicardial application of bradykinin evokes a pressor response, sometimes characterized as a nociceptive cardiovascular reflex (24), by stimulating cardiac afferent fibers that travel ir. thoracic sympathetic nerves to reach the spinal cord (21, 22, 24, 28) . Our results also confirm the observations of Staszewska-Barczak et al. in dogs that this pressor resonse is potentiated by application of PGE, to the epicardium (24) and that part of the potentiating effect of prostaglandins involves reversal or diminution of tachyphylaxis to bradykinin (23). This type of interaction between PGE, and bradykinin in eliciting responses of a nociceptive nature has been demonstrated in other systems, e.g., by injecting or infusing PGEi and bradykinin into the splenic artery of dogs (11) or into the ear artery of rabbits (14, 15, 17) and by applying these chemicals topically to the abdominal viscera in cats (25). There have been relatively few studies of the interactive effects of PGEl and bradykinin on the neural input responsible for evoking these reflex effects, however, and none of the interactive effects of PGEl and bradykinin on cardiac sympathetic afferents.
To examine the interaction of PGEl and bradykinin in both reflex and afferent experiments we applied low concentrations (0.1 pg/ml) of PGEl to the epicardium over an extended period (15 min) before applying bradykinin. Prolonged infusion of small amounts of PGE, potentiates the nociceptive cardiovascular response to arterial injection of bradykinin (11, 14, 15, 17) , PGE, administration itself having little or no cardiovascular effect. In our experiments, epicardial application of PGEl alone never produced an increase in arterial pressure, although it evoked a small but significant increase in background discharge of cardiac sympathetic afferent fibers. When PGEl is applied to the epicardium in higher concentrations (10 pg/ml), however, it stimulates sympathetic afferent fibers (9), although the reflex effects of these higher concentrations have not been recorded. Prolonged infusion of PGEl has also been found to potentiate the effects of bradykinin on afferent nerve endings. Thus Chahl and Iggo (8) found only a small increase in activity in cutaneous afferent nerves in rats when bradykinin alone was injected into the arterial supply of the region but marked stimulation if a low concentration of PGEl was infused into the artery during the 10 min before bradykinin injection. A single injection of the same total dose of PGEl was relatively ineffective.
Although Malliani et al. (19) 
(9) Effect of prostaglandin E1 (PGE1) on tachyphylaxls associated with repeated application of bradykinin to sympathetic afferent endings. A, observations on 9 mechanosensitive endings (3 fibers became inactive between applications 4 and 5, and 4 more became inactive between applications 5 and 6). B, observations on 5 chemosensitive endings (2 fibers became inactive between applicutins 4 and 5, and 1 more became inactive between applications 5 and 6). Bradykinin (1.0 a/ml) applied at 15-min intervals; PGEl (0.1 fig/ml) dripped onto epicardium (0.3 ml/min) in intervals between bradykinin applications 3-6. Open blocks, increase in impulse activity; stippled blocks, duration of evoked discharge. Data are means k SE. Numbers in parentheses indicate number of afferent fibers. Magnitude and duration of responses to bradykinin decreased significantly between applications 2 and 3 for both types of ending and were restored by PGEl (P < 0.05). Response of chemosensitive endings but not that of mechanosensitive endings was potentiated by PGE, (P < 0.05).
able from other polymodal receptors, the evidence for two quite distinct categories of afferent (1,26,27, present results) cannot be ignored. Chemosensitive fibers were first distinguished as a special class of cardiac sympathetic afferent by Uchida and Murao (27) , who described them as "mechanically resistant" although stimulated by a variety of chemicals, including bradykinin (26). Our observations (1, present results) support those of Uchida and Murao. In the present experiments chemosensitive afferents were stimulated more vigorously than mechanosensitive afferents by bradykinin, and their response was clearly potentiated, in both magnitude and duration, by PGEI. We found no clear evidence for potentiation of mechanosensitive afferents by PGE1. It seems likely, therefore, that input from chemosensitive afferents was mainly responsible for the potentiating effect of PGEI on the pressor response to bradykinin in our reflex experiments. The relatively small number of these chemosensitive afferents identified and examined in this and in our previous study (1) does not necessarily indicate that chemosensitive cardiac afferents are scarce but only that, lacking an obvious cardiac rhythm and being less sensitive than mechanosensitive afferents to mechanical manipulations, they are less easy to detect during preliminary exploration of the nerve filaments. Hence many nerve strands containing cardiac chemosensitive afferents may have been discarded unwittingly.
Sympathetic chemosensitive nerve endings in the heart do not, in general, appear to respond to stimuli within the physiological range (1, present results), and their function is probably confined to nociception. The concept of a purely nociceptive role for these afferents is supported by our observation that their response to bradykinin is potentiated by PGE1, an effect that seems to be specific for nociceptive input. Bradykinin is known to have powerful algesic properties, and pseudoaffective responses, evoked in anesthetized animals by arterial injection of bradykinin, are strongly potentiated by pre-PGE1, AND CARDIAC SYMPATHETIC AFFERENTS R821 vious infusion of PGE1 (11, 14, 15, 17) . Moreover, Belcher (3) found that although both nociceptive and nonnociceptive neurons in the dorsal horn of the cat spinal cord are activated by peripherally administered bradykinin and other algesic chemicals, only the response of nociceptive neurons was potentiated by peripherally administered PGE1.
The response of cardiac sympathetic mechanoreceptors to bradykinin application was less marked than that of their chemosensitive counterparts and, as described previously (1, 18), took the form of a sensitization to mechanical events rather than outright stimulation. Thus mechanoreceptors that discharged an impulse in occasional cardiac cycles under control conditions began to discharge regularly with each cardiac cycle after bradykinin application. In some of the afferent experiments systolic arterial pressure increased after bradykinin application, but the mechanoreceptive response was not necessarily dependent on this pressor effect and indeed often occurred in its absence. Hence the mechanosensitive endings were directly responsive to the chemical, a finding that justifies use of the term polymodal to describe them (18).
The absence of any obvious potentiating effect of PGE1 on the response of cardiac mechanosensitive endings and the striking potentiation of the response of cardiac chemosensitive endings probably reflect their different mode of activation.
Nevertheless, the responses of the two classes of afferent to bradykinin and PGEl had certain features in common. Thus tachyphylaxis to bradykinin occurred in both types of nerve ending, and tachyphylaxis was reversed by PGEl in both. In the case of cardiac chemosensitive afferents, reversal of tachyphylaxis was accompanied by potentiation of the afferent response. A comparable combination of reversal of tachyphylaxis and potentiation of the pressor response was observed in the reflex experiments. It seems likely that cardiac chemosensitive afferents were largely responsible for the reflex potentiation.
It is uncertain how PGE1 acts to minimize tachyphylaxis to bradykinin, and indeed the phenomenon of tachyphylaxis itself is incompletely understood. The general view is that tachyphylaxis to peptides is due to activity changes in the enzymes involved in the production and breakdown of cyclic AMP (13) and that physiologically active peptides, including bradykinin, exert their effects on target tissues through the adenylate cyclase-cyclic AMP system (20). The possibility that such effects are involved at sensory nerve endings is largely speculative, although a second messenger role for cyclic nucleotides at synaptic membranes in the central nervous system (6) and at the membranes of dorsal root sensory neurons (10) is fairly well established. Moreover, prostaglandins are known to increase cellular levels of cyclic AMP (7, 16), and PGE1-induced sensitization of cutaneous nerve endings to nociceptive stimuli has been shown to involve cyclic AMP (12). Hence potentiation of the response of chemosensitive cardiac afferents to bradykinin, as well as reversal of tachyphylaxis to bradykinin in both chemosensitive and mechanosensitive cardiac afferents, may be linked to a PGEl-induced increase in cyclic AMP levels in the afferent nerve terminals.
Whatever the mechanism of interaction of PGEl and bradykinin, however, our results suggest that when pathological conditions of the myocardium lead to local formation of bradykinin the simultaneous release of prostaglandins is likely to be important in promoting and maintaining the increased cardiac afferent input to the spinal cord and in potentiating the activity of nociceptive (chemosensitive) afferents whose input is likely to give rise to cardiac pain.
